Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Caroline Galeotti"'
Autor:
Véronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, Caroline Galeotti, Gilles Grateau, Aurelia Carbasse, Anne Pagnier, Pascal Pillet, Marc Delord, Michael Hofer, Sophie Georgin-Lavialle
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
Objectives: The major role of interleukin (IL)-1 in the pathogenesis of hereditary recurrent fever syndromes favored the employment of targeted therapies modulating IL-1 signaling. However the best use of IL1 inhibitors in terms of dosage is difficul
Externí odkaz:
https://doaj.org/article/bed78af1f0f64ca29e4892e6be1ec844
Autor:
Michael Hofer, Marc Delord, Pascal Pillet, Aurélia Carbasse, Sophie Georgin-Lavialle, Caroline Galeotti, Véronique Hentgen, Anne Pagnier, Gilles Grateau, Isabelle Koné-Paut, Alexandre Belot
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 11, pp.568865. ⟨10.3389/fphar.2020.568865⟩
Frontiers in Pharmacology, 2021, 11, pp.568865. ⟨10.3389/fphar.2020.568865⟩
Frontiers in Pharmacology, Vol 11 (2021)
Frontiers in Pharmacology, Frontiers, 2021, 11, pp.568865. ⟨10.3389/fphar.2020.568865⟩
Frontiers in Pharmacology, 2021, 11, pp.568865. ⟨10.3389/fphar.2020.568865⟩
Frontiers in Pharmacology, Vol 11 (2021)
Objectives: The major role of interleukin (IL)-1 in the pathogenesis of hereditary recurrent fever syndromes favored the employment of targeted therapies modulating IL-1 signaling. However the best use of IL1 inhibitors in terms of dosage is difficul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f3d779a1d276696331228262b995e0
https://hal.sorbonne-universite.fr/hal-03125751/document
https://hal.sorbonne-universite.fr/hal-03125751/document
Autor:
Isabelle Koné-Paut, Caroline Galeotti
Publikováno v:
Expert Review of Clinical Immunology. 11:1083-1092
Cryopyrin-associated periodic syndrome (CAPS) encompasses a spectrum of three phenotypes of increasing severity. The syndrome is due to dominant mutations in NLRP3, which encodes a key component of the innate immunity that regulates the secretion of
Autor:
Isabelle Koné-Paut, Caroline Galeotti
Publikováno v:
Expert Review of Clinical Immunology. 10:7-18
Cryopyrin-associated periodic syndrome (CAPS) is a very rare auto-inflammatory syndrome, which has recently served as a pure model of IL-1β-driven diseases. CAPS is caused by mutations into the NLRP3 gene that encodes crypoyrin, which serves as a re
Autor:
Isabelle Koné-Paut, Caroline Galeotti
Publikováno v:
Expert Opinion on Orphan Drugs. 1:589-597
Introduction: Cryopyrin-associated periodic syndrome (CAPS), a rare hereditary auto-inflammatory disease, is associated with mutations in the NLRP3 gene, encoding cryopyrin, a key component of the inflammasome that activates caspase-1 and IL-1β prod
Autor:
Bruno Fautrel, Isabelle Koné-Paut, Isabelle Touitou, Luca Semerano, Eric Hachulla, Linda Rossi-Semerano, Caroline Galeotti, Daniel Wendling
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, BioMed Central, 2015, 10, pp.19. ⟨10.1186/s13023-015-0228-7⟩
Orphanet Journal of Rare Diseases, 2015, 10, pp.19. ⟨10.1186/s13023-015-0228-7⟩
Orphanet Journal of Rare Diseases, BioMed Central, 2015, 10, pp.19. ⟨10.1186/s13023-015-0228-7⟩
Orphanet Journal of Rare Diseases, 2015, 10, pp.19. ⟨10.1186/s13023-015-0228-7⟩
Background Despite their limited licensed indications, anti–interleukin-1 (anti–IL-1) agents are often used in clinical practice for an increasing number of auto-inflammatory diseases. We conducted a national cross-sectional observational study f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a0076e0b79b81653ef1c6df37c0c59
https://hal.sorbonne-universite.fr/hal-01275718/document
https://hal.sorbonne-universite.fr/hal-01275718/document
Autor:
Caroline Galeotti, Linda Rossi-Semerano, Pascal Pillet, Pierre Quartier, Brigitte Bader-Meunier, Ulrich Meinzer, Isabelle Koné-Paut
Publikováno v:
Rheumatology (Oxford, England). 51(10)
Objective. To describe the efficacy and safety of IL-1-targeting drugs, anakinra and canakinumab, in patients with mevalonate kinase deficiency (MKD). Methods. A questionnaire was sent to French paediatric and adult rheumatologists to retrospectively
Autor:
I Kone-Paut, O. Richer, M Fouillet-Desjonqueres, Caroline Galeotti, D Wendling, Alain Meyer, Linda Rossi-Semerano, Bruno Fautrel, S Ottaviani, Isabelle Touitou, Eric Hachulla
Publikováno v:
Pediatric Rheumatology Online Journal
Despite their limited licensed indications, anti-IL1 agents are often used in real-life practice for an increasing number of diseases. A national survey to record their off-label use in France was started in January 2011. The survey is coordinated by